Table 2.
Number of ILD patients who reported ILD and non-ILD lung disease in their family (1 or more relatives)
| Reported disease in family | All | Sarc | HP | IPF | uPF | Non-IPF IIP | aidILD | oILD |
|---|---|---|---|---|---|---|---|---|
| N (%) | 1164 | 644 | 87 | 109 | 103 | 54 | 93 | 74 |
| Any ILD or non-ILD lung disease | 801 (69) | 430 (67) | 61 (70) | 79 (73) | 78 (76) | 35 (65) | 66 (71) | 52 (70) |
| Any ILD | 174 (15) | 103 (16) | 10 (12) | 26 (24) | 20 (19) | 1 (2) | 7 (8) | 7 (10) |
| Sarcoidosis | 109 (9) | 90 (14) | 4 (5) | 3 (3) | 5 (5) | 0 | 3 (3) | 4 (5) |
| Pulmonary fibrosis | 54 (5) | 7 (1) | 5 (6) | 22 (20) | 15 (15) | 0 | 4 (4) | 1 (1) |
| Remaining ILD | 20 (2) | 11 (2) | 1 (1) | 2 (2) | 3 (3) | 1 (2) | 0 | 2 (3) |
| Any non-ILD lung disease | 750 (64) | 395 (61) | 59 (68) | 72 (66) | 72 (70) | 35 (65) | 65 (70) | 52 (70) |
| Asthma | 253 (22) | 160 (25) | 21 (24) | 17 (16) | 9 (9) | 7 (13) | 18 (19) | 21 (28) |
| Bronchitis | 177 (15) | 101 (16) | 19 (22) | 8 (7) | 8 (8) | 9 (17) | 16 (17) | 16 (22) |
| COPD | 120 (10) | 65 (10) | 16 (18) | 8 (7) | 12 (12) | 5 (9) | 10 (11) | 4 (5) |
| Emphysema | 94 (8) | 45 (7) | 8 (9) | 11 (10) | 12 (12) | 6 (11) | 6 (7) | 6 (8) |
| Pneumonia | 82 (7) | 35 (5) | 9 (10) | 11 (10) | 10 (10) | 3 (6) | 7 (8) | 7 (10) |
| Tuberculosis | 114 (10) | 56 (9) | 8 (9) | 10 (9) | 16 (16) | 7 (13) | 9 (10) | 8 (11) |
| Lung cancer | 286 (25) | 153 (24) | 15 (17) | 39 (36) | 24 (23) | 12 (22) | 25 (27) | 18 (24) |
| Lung disease n.s | 186 (16) | 85 (13) | 15 (17) | 20 (18) | 25 (24) | 12 (22) | 14 (15) | 15 (20) |
Sarc = sarcoidosis; HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; uPF = unclassifiable pulmonary fibrosis; non-IPF IIP = an idiopathic interstitial pneumonia, other than IPF; aidILD = autoimmune disease interstitial lung disease; oILD = other interstitial lung disease; n.s. = not specified